Centron won the agency of record assignment for Cephalon’s AMRIX capsules as well as the medical education agency assignment for a new product being developed by Acorda Therapeutics.

Jocoto said it has won launch assignments from Abaxis’ animal health unit, IntraPace, Luminous Medical, Relievant Medical and a minimally invasive back surgery company. The San Francisco-based medical agency said it has seen a 25%-30% increase in spend since the economic downturn began in 2009.

Harrison and Star was named agency of record for the launch of Incyte’s Janus-Associated Kinase inhibitor currently known as INCB18424, a first-in-class compound that, if approved, could become the first drug indicated for myleofibrosis.